Literature DB >> 18790836

Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse.

Salvatore Mancarella1, Yuankun Yue, Eddy Karnabi, Yongxia Qu, Nabil El-Sherif, Mohamed Boutjdir.   

Abstract

The novel alpha1D Ca2+ channel together with alpha1C Ca2+ channel contribute to the L-type Ca2+ current (I(Ca-L)) in the mouse supraventricular tissue. However, its functional role in the heart is just emerging. We used the alpha1D gene knockout (KO) mouse to investigate the electrophysiological features, the relative contribution of the alpha1D Ca2+ channel to the global I(Ca-L), the intracellular Ca2+ transient, the Ca2+ handling by the sarcoplasmic reticulum (SR), and the inducibility of atrial fibrillation (AF). In vivo and ex vivo ECG recordings from alpha1D KO mice demonstrated significant sinus bradycardia, atrioventricular block, and vulnerability to AF. The wild-type mice showed no ECG abnormalities and no AF. Patch-clamp recordings from isolated alpha1D KO atrial myocytes revealed a significant reduction of I(Ca-L) (24.5%; P < 0.05). However, there were no changes in other currents such as I(Na), I(Ca-T), I(K), I(f), and I(to) and no changes in alpha1C mRNA levels of alpha1D KO atria. Fura 2-loaded atrial myocytes showed reduced intracellular Ca2+ transient (approximately 40%; P < 0.05) and rapid caffeine application caused a 17% reduction of the SR Ca2+ content (P < 0.05) and a 28% reduction (P < 0.05) of fractional SR Ca2+ release in alpha1D KO atria. In conclusion, genetic deletion of alpha1D Ca2+ channel in mice results in atrial electrocardiographic abnormalities and AF vulnerability. The electrical abnormalities in the alpha1D KO mice were associated with a decrease in the total I(Ca-L) density, a reduction in intracellular Ca2+ transient, and impaired intracellular Ca2+ handling. These findings provide new insights into the mechanism leading to atrial electrical dysfunction in the alpha1D KO mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790836      PMCID: PMC2614575          DOI: 10.1152/ajpheart.00537.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  27 in total

1.  Predetermined recruitment of calcium release sites underlies excitation-contraction coupling in rat atrial myocytes.

Authors:  L Mackenzie; M D Bootman; M J Berridge; P Lipp
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

2.  Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity.

Authors:  Matteo E Mangoni; Brigitte Couette; Emmanuel Bourinet; Josef Platzer; Daniel Reimer; Jörg Striessnig; Joël Nargeot
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

3.  Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation.

Authors:  B J Brundel; I C van Gelder; R H Henning; A E Tuinenburg; L E Deelman; R G Tieleman; J G Grandjean; W H van Gilst; H J Crijns
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

4.  Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines.

Authors:  W Xu; D Lipscombe
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

5.  Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation.

Authors:  Y Namkung; N Skrypnyk; M J Jeong; T Lee; M S Lee; H L Kim; H Chin; P G Suh; S S Kim; H S Shin
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

6.  Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness.

Authors:  B C Knollmann; A N Katchman; M R Franz
Journal:  J Cardiovasc Electrophysiol       Date:  2001-11

7.  alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages.

Authors:  A Koschak; D Reimer; I Huber; M Grabner; H Glossmann; J Engel; J Striessnig
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

8.  Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice.

Authors:  Jan Matthes; Leyla Yildirim; Georg Wietzorrek; Daniel Reimer; Jörg Striessnig; Stefan Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-14       Impact factor: 3.000

Review 9.  Learning about cardiac calcium signaling from genetic engineering.

Authors:  Martin Morad; My Chau
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

10.  Functional basis of sinus bradycardia in congenital heart block.

Authors:  Keli Hu; Yongxia Qu; Yuankun Yue; Mohamed Boutjdir
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

View more
  26 in total

1.  Silencing of Cav1.2 gene in neonatal cardiomyocytes by lentiviral delivered shRNA.

Authors:  Eddy Karnabi; Yongxia Qu; Salvatore Mancarella; Yuankun Yue; Raj Wadgaonkar; Mohamed Boutjdir
Journal:  Biochem Biophys Res Commun       Date:  2009-05-05       Impact factor: 3.575

2.  Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.

Authors:  Eddy Karnabi; Yongxia Qu; Salvatore Mancarella; Mohamed Boutjdir
Journal:  J Cardiovasc Electrophysiol       Date:  2011-02-25

3.  Perinatal and postnatal expression of Cav1.3 α1D Ca²⁺ channel in the rat heart.

Authors:  Yongxia Qu; Eddy Karnabi; Omar Ramadan; Yuankun Yue; Mohamed Chahine; Mohamed Boutjdir
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

4.  The genome sequence of the spontaneously hypertensive rat: Analysis and functional significance.

Authors:  Santosh S Atanur; Inanç Birol; Victor Guryev; Martin Hirst; Oliver Hummel; Catherine Morrissey; Jacques Behmoaras; Xose M Fernandez-Suarez; Michelle D Johnson; William M McLaren; Giannino Patone; Enrico Petretto; Charles Plessy; Kathleen S Rockland; Charles Rockland; Kathrin Saar; Yongjun Zhao; Piero Carninci; Paul Flicek; Ted Kurtz; Edwin Cuppen; Michal Pravenec; Norbert Hubner; Steven J M Jones; Ewan Birney; Timothy J Aitman
Journal:  Genome Res       Date:  2010-04-29       Impact factor: 9.043

Review 5.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

Review 6.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

7.  Role of abnormal sarcoplasmic reticulum function in atrial fibrillation.

Authors: 
Journal:  Therapy       Date:  2010-03-01

8.  Calreticulin negatively regulates the surface expression of Cav1.3 L-type calcium channel.

Authors:  Eddy Karnabi; Yongxia Qu; Yunkun Yue; Mohamed Boutjdir
Journal:  Biochem Biophys Res Commun       Date:  2013-06-17       Impact factor: 3.575

9.  Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.

Authors:  Shane R Cunha; Thomas J Hund; Seyed Hashemi; Niels Voigt; Na Li; Patrick Wright; Olha Koval; Jingdong Li; Hjalti Gudmundsson; Richard J Gumina; Matthias Karck; Jean-Jacques Schott; Vincent Probst; Herve Le Marec; Mark E Anderson; Dobromir Dobrev; Xander H T Wehrens; Peter J Mohler
Journal:  Circulation       Date:  2011-08-22       Impact factor: 29.690

Review 10.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.